MJ - ETFMG Alternative Harvest ETF

NYSEArca - Nasdaq Real Time Price. Currency in USD
39.241
-0.469 (-1.18%)
As of 9:38AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close39.710
Open39.700
Bid39.000 x 900
Ask39.700 x 1400
Day's Range39.241 - 39.950
52 Week Range0.740 - 45.399
Volume76,601
Avg. Volume803,352
Net Assets678.89M
NAV39.70
PE Ratio (TTM)N/A
Yield1.85%
YTD Return23.58%
Beta (3Y Monthly)0.00
Expense Ratio (net)0.79%
Inception Date2015-12-03
Trade prices are not sourced from all markets
  • October Update: What Analysts Recommend for Organigram
    Market Realist2 hours ago

    October Update: What Analysts Recommend for Organigram

    Organigram (OGRMF) had one of its best days on October 15 with a rise ~9.3% to 8.2 Canadian dollars. It appears that cannabis stocks continue to be a favorite among investors, as stocks such as Cronos Group (CRON), Tilray (TLRY), and Canopy Growth (CGC) (WEED) all gained over 10% during the day.

  • MarketWatchyesterday

    Marijuana stocks sink as full legalization in Canada fails to inspire investors

    Shares of companies in the cannabis business were broadly, and in many cases sharply lower, despite marijuana becoming fully legal in Canada. The ETFMG Alternative Harvest ETF tumbled 6.5% in morning trade, with 27 of 37 components trading lower, to extend Tuesday's 3.7% pullback. Among the more active pot stocks, Canopy Growth Corp. dropped 8.2%, Tilray Inc. lost 6.0%, Aurora Cannabis Inc. plunged 15%, Cronos Group Inc. slumped 9.9%, New Age Beverages Corp. shed 9.0%, India Globalization Capital Inc. slid 7.3% and MedMen Enterprises Inc. lost 6.0%. As of Wednesday, Canada became only the second country in the world to legalize marijuana for recreational use. The pot sector ETF has now gained 39% over the past three months, while the S&P 500 has slipped 0.2%. More about the emerging cannabis sector: A guide to pot stocks: What you need to know to invest in cannabis companies

  • Benzinga2 days ago

    Rapper Berner Talks Cannabis Business Ventures, Shares Advice For Entrepreneurs

    Rapper Berner's most recent collaborations are with famous, marijuana-loving musicians like Wiz Khalifa, Snoop Dogg and B-Real. Berner is often credited with the creation of some of the most popular marijuana strains in the U.S., including Girl Scout Cookies, Gelato and Snowman. The serial entrepreneur and rapper first brought up his cannabis, accessories and clothing brand Cookies.

  • Price Target Update for Canopy Growth in October
    Market Realist2 days ago

    Price Target Update for Canopy Growth in October

    Without a doubt, Canopy Growth (CGC)(WEED) has been one of the hottest cannabis stocks on the market (MJ). The company is one of the most valuable companies, ahead of Aurora Cannabis (ACB) (ACBFF) and Aphria (APHQF). The overall consensus recommendation for Canopy Growth in October is a “buy.” As the above chart shows, two analysts maintained a “strong buy” on the stock, while five analysts maintained a “buy” recommendation on the stock in the current month.

  • MarketWatch2 days ago

    Green Organic Dutchman's stock surges after receipt of medical cannabis sales license

    Shares of Green Organic Dutchman Holdings Ltd. surged 5.3% in premarket trade Tuesday, after the organic medical cannabis company said it received its medical sales license from Health Canada. The license is in accordance with the Access to Cannabis for Medical Purposes Regulations for the Canada-based company's Ancaster, Ontario facility. "As we prepare for our Founders Club product launch in January 2019, this is a critical step in our path to becoming the global leading organic cannabis brand," said Chief Executive Brian Athaide. "We have been perfecting our organic grow methodology in Ancaster and are prepared for the Q1 launch to medical patients across Canada followed by the launch in adult use markets in Q2." The stock has gained 0.5% over the past three months, while the ETFMG Alternative Harvest ETF has rallied 52.5% and the S&P 500 has slipped 1.7%.

  • MarketWatch2 days ago

    Tilray's stock surges after Benchmark starts coverage with bullish rating, $200 target

    Shares of Tilray Inc. shot up 5.7% in premarket trade Tuesday, after Benchmark analyst Mike Hickey started coverage of the Canada-based medical cannabis and cannabinoid company with a buy rating and $200 price target. Hickey's price target is 21% above Monday's closing price $165.64. Hickey said his bullish view is based on the company's early leadership in the medical cannabis market in Canada, the upcoming full legalization of recreational marijuana in Canada and its strategic alliance with Novartis AG and supply agreements with Canadian pharmacies, international growth opportunities and a "meaningful" capital infusion from its initial public offering in July. "We believe establishing an early first mover advantage is critically important in the emerging cannabis market, particularly when it comes to building national and global scale, leading brands, and developing innovative products and form factors that use cannabis as an active ingredient," Hickey wrote in a note to clients. The stock has rocketed more than 7-fold since closing at $22.39 on its first day listed on the Nasdaq on July 19, while the ETFMG Alternative Harvest ETF has run up 55% and the S&P 500 has lost 1.9% over the same time.

  • ETF Trends3 days ago

    Marijuana ETF Jumps After Canopy Growth Buys U.S. Hemp Researcher

    A marijuana ETF climbed Monday after Canopy Growth (CGC) announced it acquired U.S. hemp company, Ebbu, to expand its product line. The ETFMG Alternative Harvest ETF (MJ) , first U.S.-listed ETF to target the cannabis and marijuana industry, increased 5.8% Monday. Canopy Growth argued that its acquisition will "complement and accelerate" its ambitions to expand into new types of consumer products, CNBC reports.

  • This Sin-Stock ETF's Marijuana Moves Have Missed the Mark
    Motley Fool3 days ago

    This Sin-Stock ETF's Marijuana Moves Have Missed the Mark

    The fund invests in cannabis -- but read the fine print.

  • Benzinga5 days ago

    Amy Margolis Shares Her Cannabis Story, Legal Advice: 'Entrepreneurs Need To Be Nimble, Adaptable And Willing To Pivot'

    Amy Margolis has been practicing law for more than 15 years. Not long ago, Margolis opened The Commune, a 4,000-square-foot venue for marijuana-friendly events with office and boardroom space. Why did Margolis get into cannabis work?

  • Investor's Business Daily6 days ago

    Here's What You Should Do If Your ETF Undergoes An Index Change

    When the composition of an index changes, ETFs that track it must adjust their holdings. Such an index change can have significant consequences for investors.

  • ETF Trends6 days ago

    Marijuana ETF and Cannabis Stocks Green Amid a Sea of Red

    Investors have been seeing a lot of red the past couple of days, but rising amid the Dow Jones Industrial's 1,300-point loss in the last two trading sessions are the ETFMG Alternative Harvest ETF (MJ) and cannabis stocks-- Tilray (TLRY) and Canopy Growth Corporation (CGC) . All three were up as of 1:15 p.m. ET--MJ rose 3.5%, TLRY up almost 8% and CGC ticked higher 2.8% as the Dow attempts to pare its losses this week. Tilray, in particular, saw its valuation multiply almost tenfold thus far this year after a frenzy of investor interest last month skyrocketed its stock price to over $250 before selling off to its current level of $140.  MJ, The first U.S.-listed ETF to target the cannabis and marijuana industry, is now up 23.58% year-to-date and 30.35% within the past year, according to Yahoo! Finance performance numbers.

  • Benzinga6 days ago

    Is Blockchain A Solution To The Cannabis Industry's Banking Challenges?

    It's estimated that legal cannabis sales in the U.S. could reach $10 billion this year and more than double within the next five to six years. The sector continues to face many challenges, such as an inability to work with banks, a constantly changing regulatory environment and the problem of attracting investors.  Cryptocurrencies: A Solution To Weed Industry's Banking Problems? American cannabis companies are predominantly cash-only businesses.

  • InvestorPlace7 days ago

    Fans of Tilray Stock Ought to Ride MJ to Success

    It seems that anyone who invests in marijuana stocks these days has a fundamental reason why they’re backing a particular horse in what’s become the world’s biggest stakes race.10 S&P 500 Stocks to Buy for the Long Term

  • MarketWatch7 days ago

    MedMen to buy medical cannabis company PharmaCann in a $682 million stock deal

    Cannabis company MedMen Enterprises Inc. announced Thursday a binding letter of intent to buy medical cannabis provider PharmaCann LLC in a stock deal valued at $682 million. The combined company would have cannabis licenses in 12 states that would allow it to operate 79 cannabis facilities. "This is a transformative acquisition that will create the largest U.S. cannabis company in the world's largest cannabis market," said MedMen Chief Executive Adam Bierman. MedMen's stock, which closed Wednesday at $4.22, has rallied 11% over the past three months, while the ETFMG Alternative Harvest ETF has run up 30% and the S&P 500 has gained 0.4%.

  • 679 Million Reasons the Marijuana Stock Craze Should Scare You
    Motley Fool7 days ago

    679 Million Reasons the Marijuana Stock Craze Should Scare You

    When investment flows come in quickly, they can go out just as quickly.

  • MarketWatch9 days ago

    Tilray stock price target raised to over 10-times the IPO price at Cowen

    Tilray Inc.'s stock price target was nearly tripled at Cowen & Co. to more than 10-times the cannabis company's initial public offering price, with analyst Vivien Azer calling seeing a large total addressable market (TAM) opportunity supported by existing demand. Azer raised her target on the stock to $172, which is 34% above current levels. The stock, which went public on July 19 at an IPO price of $17, fell 7.5% in morning trade, but was still up 66% over the past month.Meanwhile, the ETFMG Alternative Harvest ETF has gained 12% the past month while the S&P 500 has edged up 0.6%. "While we had initially focused on the adult use opportunity when we launched on cannabis over two years ago, the well-capitalized cannabis industry has been evolving rapidly and looks to address a far larger TAM than we had originally forecast," Azer wrote in a note to clients. She envisions four key business lines for outperform-rated Tilray and its peers, such as adult use, beauty and nutraceuticals, over-the-counter pain and sleep and pharmaceuticals.

  • Barrons.com13 days ago

    What’s Next for the ETF Industry—and Your Portfolio

    When exchange-traded funds first arrived in the early 1990s, they were primarily tools for professional traders and investors. ETFs certainly weren’t expected to make big inroads into asset-gathering at the expense of mutual funds, threaten Wall Street’s profits, change the financial advisory business, or be likened to encroaching Marxism.

  • Why Constellation Brands Sees Value in Canopy Growth
    Market Realist13 days ago

    Why Constellation Brands Sees Value in Canopy Growth

    During Constellation Brands’ (STZ) earnings call, the company offered insight into its rationale on choosing Canopy Growth (WEED) (CGC) as its partner in the cannabis industry. Constellation Brands mentioned Canopy Growth’s large share in supplying cannabis for recreational use in Canada, as you can see in the following chart. Constellation Brands stated that it chose Canopy Growth because it’s a medical cannabis leader in Canada.

  • Benzinga14 days ago

    A Scrappy Silicon Valley Entrepreneur And His Cannabis-Infused Battle Against Opioids

    Launched in 2016, Heally is a software solution that connects consumers to knowledgeable medical professionals and high-quality health and wellness products with an emphasis on cannabis. Heally’s “telehealth” platform connects patients with physicians who provide advice and consultation. In states where medical cannabis cards are still needed, patients can obtain one using Heally.

  • Top Performing ETFs of the Third Quarter
    Zacks14 days ago

    Top Performing ETFs of the Third Quarter

    Healthcare emerged as the new leader in Q3. Here is what investors need to know about best performing sectors and ETFs.

  • Tilray Gains 13.5% on October 3, Falls in After-Market Trading
    Market Realist14 days ago

    Tilray Gains 13.5% on October 3, Falls in After-Market Trading

    On October 3, Tilray (TLRY) gained 13.5% to close the day at $156.80 per share. Tilray announced on October 3 after the market closed that it intends to raise $400 million of convertible senior notes from the private market through the exempt (for prospectus) market in Canada. Cannabis companies (MJ) Canopy Growth (CGC) (WEED), Aurora Cannabis (ACB), and Cronos (CRON) have seen a huge need for capital lately, and Tilray is no different.

  • The 7 Best ETFs of the Third Quarter
    InvestorPlace16 days ago

    The 7 Best ETFs of the Third Quarter

    Domestic stocks impressed in the third quarter with the S&P 500 finishing the July through September period with a gain of 7.4%. Even with that, the number of exchange-traded funds (ETFs) posting third-quarter gains of 10% or more is not particularly gaudy.

  • MarketWatch16 days ago

    IGC stock rockets, but pares some gains after short-seller Citron takes aim

    India Globalization Capital Inc. , known by cannabis investors as IGC, ran up 53% in midday trade Tuesday, but has pared earlier gains of as much as 62%, after famed short seller Andrew Left's Citron Research tweeted, "This hype stock is the poster child of a cannabis bubble." Citron said investors able to short the stock, they should consider it a "gift," as the company has no product and is "all hype." Citron said it has a target on the sock at "$6 fast," which would be 56% below current levels. The stock started shooting higher last week, after the company said it entered the cannabidiol-infused energy drink market with its agreement to distribute "Nitro G." The stock has rocketed 2,682% over the past three months, while the ETFMG Alternative Harvest ETF has climbed 36% and the S&P 500 has gained 7.4%.

  • Top and Flop ETFs of September
    Zacks17 days ago

    Top and Flop ETFs of September

    Inside the winning and losing ETFs of September.

  • Top & Flop Zones of Q3 & Their ETFs
    Zacks17 days ago

    Top & Flop Zones of Q3 & Their ETFs

    Some corners of ETF investing have performed exceptionally well in the third quarter while some are lagging.